US Patent 7345051 Mucin synthesis inhibitors
Patent 7345051 was granted and assigned to Genaera on March, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+399 characters)
Article
Patent abstract
The claimed invention relates to methods of modulating mucin synthesis and the therapeutic application of compounds of Formula II in controlling mucin over-production associated with diseases such as chronic obstructive pulmonary diseases (COPD) including asthma and chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic respiratory infectious diseases.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07345051 Mucin synthesis inhibitors US Patent 7345051 Mucin synthesis inhibitors
Infobox
Patent Number
0734505100
Patent Number
734505100
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073450510
Date of Patent
March 18, 2008
0Patent Application Number
102904430
Date Filed
November 8, 2002
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073450510
Date of Patent
March 18, 2008
0Patent Application Number
102904430
Date Filed
November 8, 2002
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 24 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07345051 Mucin synthesis inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07345051
Date of patent
March 18, 2008
Patent application number
10290443
Date Filed
November 8, 2002
Patent primary examiner
Find more entities like US Patent 7345051 Mucin synthesis inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
